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ABSTRACT 
Summary: The coronavirus disease 2019 (COVID-19) caused by a new type of 
coronavirus has been emerging from China and led to thousands of death globally since 
December 2019. Despite many groups have engaged in studying the newly emerged virus 
and searching for the treatment of COVID-19, the understanding of the COVID-19 target 
-ligand interactions represents a key challenge. Herein, we introduce COVID-19 Docking 
Server, a web server that predicts the binding modes between COVID-19 targets and the 
ligands including small molecules, peptide and antibody. Structures of proteins involved 
in the virus life cycle were collected or constructed based on the homologs of coronavirus, 
and prepared ready for docking. The platform provides a free and interactive tool for the 
prediction of COVID-19 target-ligand interactions and following drug discovery for 
COVID-19. 
Availability and implementation: The COVID-19 Docking Server and tutorials 
are freely available at http://ncov.schanglab.org.cn 
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1. INTRODUCTION 
According the situation report from World Health Organization (WHO), more than 
75,000 cases of coronavirus disease 2019 (COVID-19) have been reported among 25 
countries till February 21, 2020. As the first COVID-19 case was reported in Wuhan city, 
Hubei province of China in December 2019, concentrated pneumonia occurred in China, 
especially in Wuhan. The pathogen caused the disease was soon identified as a novel 
coronavirus, which belongs to the genus Betacoronavirus and is closely related to severe 
acute respiratory syndrome coronavirus (SARS-CoV) with 89.1% nucleotide similarity in 
the viral genome1, 2. Later on, it was named as severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) by the International Committee on the Taxonomy of 
Viruses. Tremendous effects have been done to study the newly emerged virus and find 
potent drugs for clinical usage. Wang et. al from Wuhan Institute of Virology screened 
some of the FDA approved anti-virus or anti-infection drugs and found that remdesivir 
and chloroquine could effectively inhibit the virus in cell based assay with EC50 of 0.77 
and 1.13 μM, respectively3. Several clinical trials are ongoing for the treatment of 
COVID-19. However, no drug or vaccine has yet been approved.  
In a very short time, the structures of functional proteins essential for SARS-CoV-2 
were achieved by groups in China, including the main protease and spike protein in 
binding with angiotensin-converting enzyme 2 (ACE2). Although the structures of other 
proteins remain unknown, the high amino acid identity between SARS-CoV-2 and 
SARS-CoV (77.2%) enables that it is possible to establish the homology modeled 
structures of SARS-CoV-2 based on the protein structures of SARS-CoV with high 
confidence. Thus, we built and collected the protein structures as potential targets of 
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SARS-CoV-2 according to those of SARS-CoV. A web-server, COVID-19 Docking 
Server, was constructed to facilitate people to evaluate the binding modes and binding 
affinities between these targets and small molecules, peptides as well as antibodies. By 
launching the server, we’d like to provide a free and easy to use tool for people who is 
interested in drug discovery against COVID-19. 
2. METHODS AND MATERIALS 
2.1 Protocol of COVID-19 Docking Server 
The flow chart of the COVID-19 Docking Server is shown in Figure 1. For small 
molecule docking, Autodock Vina4 is used as docking engine. Two computational type 
are provided with the default computational type as “Docking” (D) to dock single small 
molecule to the target, and the other option “Screening” (S) to dock a number of small 
molecules to the target.  The protein structures of COVID-19 targets were extracted and 
prepared by MGLTools 1.5.6. User only needs to upload the small molecules in smi, 
mol2 or sdf formats. Open Babel was used for format transformation or 3D coordinate 
generation for the uploaded files5. Then ligand_prepare.py from MGLTools 1.5.6 is used 
to convert the ligand files into pdbqt format with Gasteiger charge added. The box center 
for docking was defined according to the information of active sites or binding sites of its 
homologs of SARS-CoV. All the parameters are set as default except the exhaustiveness 
value is set to 12 to achieve higher accuracy.  
For peptide and antibody docking, CoDockPP6 is used as docking engine. Two 
options are provided with the default (D) option as global docking and the other one as 
site-specific (S) docking with constraints defined by user. CoDockPP program takes full 
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advantage of the sampling efficiency of FFT-based method to perform the global 
searching. An angle interval of 15º is used for rotational sampling, and a spacing of 1.2 Å 
is adopted for fast Fourier transform (FFT) translational search. CoDockPP uses a precise 
knowledge-based scoring function to evaluate the candidate poses after FFT searching. 
Finally, the top binding modes are clustered with ligand root mean square deviations 
(L_RMSD) cutoff of 3.0 Å in global docking and 2.0 Å in site-specific docking. 
The COVID-19 Docking Server web interface is written in PHP and HTML. JSMol 
(http://jmol.sourceforge.net/) is used for molecular visualization on the results pages. 
 
Figure 1. The flow chart of the COVID-19 Docking Server. For small molecule docking, 
default (D) computational type is “Docking”, to dock single molecule by AutoDock Vina. 
The other type is “Screening” (S), to dock a number of molecules by AutoDock Vina. For 
peptide and antibody docking, default (D) option is global docking by CoDockPP. The 
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other type is site-specific (S) docking with the user-defined constraint information by 
CoDockPP. Finally, the Top 10 binding modes (docking) or molecules (screening) are 
viewed by JSmol. 
2.2 COVID-19 Targets in the server 
The structures of functional or structural proteins of SARS-CoV-2 were collected or 
built based on its homologs of coronavirus by using homology modeling module of 
Maestro 10 (www.schrodinger.com). All the targets were prepared and available for 
peptides or antibodies docking on the website. For small molecule docking, the docking 
box was carefully defined for every specific target. Only the targets with enzyme active 
site, substrate binding site or inhibitor binding site were prepared and set for small 
molecule docking. The detailed information about the targets is described as below. 
2.2.1 Nonstructural proteins 
Main protease (Mpro): It is also named as chymotrypsin-like protease (3CLpro). 
Mpro cleaves most of the sites in the polyproteins and the products are nonstructural 
proteins (nsps) which assemble into the replicase-transcriptase complex (RTC). The 
structure was downloaded from the Protein Data Bank (PDB) with code of 6LU7. The 
substrate binding site was defined as the docking box for small molecule docking. 
Papain-like protease (PLpro): PLpro cleaves the nsp1/2, nsp2/3 and nsp3/4 
boundaries. It works with Mpro to cleave the polyproteins into nsps. The structure of 
PLpro was built based on 4OW0, the PLpro structure of SARS-CoV 7. The substrate 
binding site was defined as the docking box for small molecule docking. 
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Nonstructural protein 13 (nsp13, helicase): The helicase catalyzes the unwinding of 
duplex oligonucleotides into single strands in an NTP-dependent manner. It is also an 
ideal target to develop anti-viral drugs due to its sequence conservation in all CoV 
species. The structure of helicase was built based on 6JYT, the helicase structure of 
SARS-CoV 8. Two sites were defined for small molecule docking: the ADP binding site 
(ADP site), and the nucleic acids binding site (NCB site). 
Nonstructural protein 12 (nsp12, RNA-dependent RNA polymerase, RdRp): 
Nsp12 is the polymerase which bounds to its essential cofactors, nsp7 and nsp8. It is 
important in replication and transcription of the viral genome. The structure of RdRp was 
built based on 6NUR, the RdRp structure of SARS-CoV 9. Two structures were prepared 
for small molecule docking: One structure is constructed with RNA from its homolog 
protein (3H5Y), while the other one with no RNA in it. 
Nonstructural protein 14 (nsp14, N-terminal exoribonuclease and C-terminal 
guanine-N7 methyl transferase): Nsp14 of coronaviruses (CoV) is important for viral 
replication and transcription. The N-terminal exoribonuclease (ExoN) domain plays a 
proofreading role for prevention of lethal mutagenesis, and the C-terminal domain 
functions as a guanine-N7 methyl transferase (N7-MTase) for mRNA capping. The 
structure of nsp14 was built based on 5C8S, the nsp14 structure of SARS-CoV10. Two 
sites were prepared for small molecule docking. One is defined as the active site of the 
ExoN, and the other one is defined as the active site of N7-MTase.  
Nonstructural protein 15 (nsp15, Uridylate-specific endoribonuclease): Nsp15 
forms a hexameric endoribonuclease that preferentially cleaves 3' of uridines, also named 
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as Uridylate-specific endoribonuclease. It is one of the RNA-processing enzymes 
encoded by the coronavirus. The structure of nsp15 was built based on 2RHB, the nsp15 
structure of SARS-CoV11. The docking box was defined to include the enzyme active site 
of one of the chain from the hexamer.  
Nonstructural protein 16 (nsp16, 2'-O-methyltransferase): Nsp16 is a S-
adenosylmethionine (SAM) dependent nucleoside-2’-O methyltransferase. It is only 
active with the binding of nsp10. The structure of nsp16 was built based on 2XYR, the 
nsp16 structure of SARS-CoV12. The SAM binding site was defined as docking box for 
small molecule docking. 
Nonstructural protein 10 (nsp10): It is essential cofactor and forms complex with 
nsp14 and 16. The structure of nsp10 was built based on 2XYR, the nsp10 structure of 
SARS-CoV12. It was prepared only for protein docking on the web-server. 
 
Figure 2. The cartoon forms of nonstructural proteins. (A) Main protease. (B) Papain-
like protease. (C) Helicase. (D) RNA-dependent RNA polymerase. (E) Nsp14. (F) Nsp15. 
(G) Nsp16. (H) Nsp10. 
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2.2.2 Structure proteins 
Spike protein (S protein): The surface spike glycoprotein is consisting of three S1-
S2 heterodimers. The receptor binding domain (RBD) located on the head of S1 and bind 
with the cellular receptor angiotensin-converting enzyme 2 (ACE2), initiating the 
membrane fusion of the virus and host cell. Recently, the structure of spike RBD of 
SARS-CoV-2 in complex with human ACE2 was released by Wang and Zhang’s group 
in Tsinghua University. The structure was downloaded and prepared for protein docking. 
We also built the monomer and trimer structure of full length spike protein based on 
6ACG and prepared for protein docking 13. 
S2 of S protein: It is the post-fusion state of S2 segment of spike protein, acting as 
viral fusion protein to mediate the membrane fusion of virus and cells. Typical HR1/HR2 
6-helices complex were formed as post-fusion state of SARS-CoV-2, similar to the fusion 
step of HIV-1 virus. It is a potential target for entry inhibitor development. The 6-helices 
post fusion conformation of S2 was built based on 1WYY14. A 5-helices structure was 
prepared by deleting one of the helix from the 6-helices structure and used as receptor for 
protein or peptide docking.  
Envelop small membrane protein (E protein): It forms pentamer and functions as 
ion channel, also named as E channel. The structure of E channel was built based on 
5X29 15. Both the monomer and the pentamer were prepared for protein docking. And the 
E channel structure was also prepared for small molecule docking with the center of ion 
channel defined as box center in docking. 
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Membrane protein (M protein): The M protein involves in most of protein-protein 
interactions required for assembly of coronaviruses and it is also determined as a 
protective antigen in humoral responses16. The structure of M protein was built by using 
I-TASSER server and prepared for protein docking 17-19. 
Nucleocapsid protein (N protein): N protein plays multiple roles in the virus 
replication cycle and forms a ribonucleoprotein complex with the viral RNA through the 
N protein's N-terminal domain (N-NTD). It buds the viral genomes into the membrane of 
the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) containing the viral 
structure proteins to form the mature virions finally 16. The full length structure of N 
protein was built by using I-TASSER server and prepared for protein docking 17-19. The 
ribonucleotide-binding site (NCB site) of N protein was built based on 4KYJ and also 
prepared ready for small molecule docking 20. 
Angiotensin-converting enzyme 2 (ACE2): The structure of human ACE2 was 
extracted from the complex structure of SARS-CoV-2 spike RBD and human ACE2 
released by Wang and Zhang’s group in Tsinghua University. 
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Figure 3. The cartoon forms of structural proteins. (A) Trimer of S protein. (B) S2 of S 
protein. (C) E protein. (D) M protein. (E) N protein. (F) ACE2. 
3. RESULTS AND DISCUSSION  
3.1 Usage of small molecule docking 
For each job of small molecule docking, the user can choose one of the COVID-19 
targets. The small molecules should be uploaded in strict smi,  mol2 or sdf formats. The 
user needs to choose the computational modes before uploading the small molecule files: 
if “Docking” is selected, only one small molecule should be uploaded, and top 10 binding 
modes will be displayed on the result page. If “screening” is selected, 10-20 molecules 
should be uploaded, and the top 10 molecules ranked by the scoring function will be 
displayed on the result page. If 1-10 molecules need to be evaluated, then the user has to 
upload the molecules one by one and choose the “Docking” mode. After the submission, 
an email will be sent to user’s email address, containing a directed link to access the 
docking results. After the job completes, the user could enter the job ID to access the 
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result page. By default, the server only displays the top 10 models. The selected COVID-
19 protein target is renamed as Input_R.pdb. The top 10 models are named as 
TopL1.pdb-TopL10.pdb, respectively. The scored file is named as Score.dat. The models 
are visualized in 3D by JSmol and the user can view and download the docking results 
from the result page.   
Here, we take Papain-like protease and its inhibitor as an example for small molecule 
docking 7. The “Docking” mode was selected and the mol2 format of its inhibitor in PDB 
4OW0 was uploaded as ligand. For the top rank binding modes, the predicted binding 
energies of Top 1 and 2 were -11.5 kcal/mol and -10.7 kcal/mol, and the L_RMSDs were 
0.23Å and 3.60 Å, respectively. As shown in Figure 4A, the best binding mode of the 
inhibitor is very similar to the complex structure. 
3.2 Usage of peptide and antibody docking 
Similar to small molecule docking, the user needs to choose the COVID-19 protein 
target and uploads ligand protein (peptide or antibody) in strict pdb format for peptide or 
antibody docking. The protein docking server can perform global docking and site-
specific docking to predict the binding mode between COVID-19 protein target and 
peptide (or antibody). The user could enter one residue into either the receptor box or the 
ligand box, or he could enter one residue into receptor box and one into the ligand box 
simultaneously. If only one residue on the ligand or receptor is defined, then the 
conformations with the specific residue on the interface of the complex are retained. 
When the user defines one residue on the receptor and the other one on the ligand 
simultaneously, then he needs to choose the constraint type: ambiguous constraints 
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or multiple constraints. When the “ambiguous constraints” is selected, the conformations 
are retained with at least one selected residue on the interface. When the “multiple 
constraints” is selected, the conformations are retained with both of the residues on the 
interface.   
We use the post-fusion state of S2 segment of spike protein as an example for peptide 
docking. The receptor is 5-helices structure extracted from the post-fusion state of 6-
helices S2.  One helix was extracted from the S2 structure and used as ligand peptide. 
The pdb file of ligand peptide was uploaded and the default global docking mode was 
chosen. In our example, the predicted binding energies of Top 1 and 2 binding modes 
were -532.3 kcal/mol and -374.3 kcal/mol, and the L_RMSDs were 0.77 Å and 2.62 Å, 
respectively. As shown in Figure 4B, the best binding mode is very similar to the 6-
helices structure of spike protein. 
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Figure 4. COVID-19 Docking Server outputs. (A) An example of small molecule 
docking. The Papain-like protease docked with its inhibitor. The complex structures of 
Papain-like protease with its inhibitor are colored gray. The predicted structures of Top 1 
and 2 are colored pink and orange. (B) An example of peptide docking. The post-fusion 
state of S2 segment of spike protein docked with a helical peptide. The 6-helices structure 
of S2 is colored gray. The predicted structures of Top 1 and 2 are colored pink and 
orange. 
4. CONCLUSION 
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The structures of potential targets of COVID-19 were collected or built based on the 
homology structures of coronavirus. An online interactive server, COVID-19 Docking 
Server, was constructed to predict the binding modes between the targets and small 
molecules, peptides or antibodies by implement of Autodock Vina and CoDockPP as 
docking engines. The server provides a user-friendly interface and binding mode 
visualization for the results, which makes it a useful tool for drug discovery of COVID-
19. 
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